Haloprogin
Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.
 | |
| Clinical data | |
|---|---|
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.169  |
| Chemical and physical data | |
| Formula | C9H4Cl3IO |
| Molar mass | 361.38 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 113.5 °C (236.3 °F) |
| Solubility in water | Insoluble mg/mL (20 °C) |
| |
| |
| (verify) | |
Action
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over-the-counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[1]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]
References
- "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17.
- "Haloprogin". DrugBank. University of Alberta. Nov 6, 2006. Retrieved 2007-02-17.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.